10,653 Shares in Encompass Health Corporation $EHC Purchased by Bleakley Financial Group LLC

Bleakley Financial Group LLC acquired a new position in shares of Encompass Health Corporation (NYSE:EHC) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 10,653 shares of the company’s stock, valued at approximately $1,306,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. WPG Advisers LLC bought a new stake in shares of Encompass Health in the 1st quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Encompass Health by 749.0% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after buying an additional 367 shares during the last quarter. Park Place Capital Corp bought a new stake in Encompass Health in the second quarter worth $72,000. Arlington Trust Co LLC grew its stake in shares of Encompass Health by 22.9% in the first quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock worth $68,000 after acquiring an additional 125 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of Encompass Health by 19.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after acquiring an additional 115 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC opened at $126.23 on Friday. Encompass Health Corporation has a one year low of $87.85 and a one year high of $127.99. The business has a fifty day moving average of $124.23 and a 200 day moving average of $118.20. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The firm has a market capitalization of $12.71 billion, a P/E ratio of 24.70, a PEG ratio of 2.21 and a beta of 0.93.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The business had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, sell-side analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.19 per share. The ex-dividend date is Friday, January 2nd. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. Encompass Health’s dividend payout ratio (DPR) is presently 14.87%.

Insiders Place Their Bets

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president owned 18,846 shares of the company’s stock, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

EHC has been the topic of several recent analyst reports. UBS Group increased their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Thursday, October 2nd. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research report on Friday. Truist Financial upped their price objective on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research report on Thursday, August 14th. Zacks Research upgraded Encompass Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 21st. Finally, Bank of America boosted their price target on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Two investment analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $139.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.